baber/WOPTO huggingface dataset:
Patent NZ-538623-A (NZ)
Title: High free shrink, high modulus, low shrink tension thermoplastic film with elastic recovery
Inventor: ROBERTS WILLIAM P
IPC: B29K105/02
Filed: 2003-08-05
Abstract: Disclosed herein is a heat shrinkable thermoplastic film comprising: (a) a core layer comprising at least about 65 percent by weight of a homogeneous alpha-olefin/cyclic olefin random copolymer having a glass transition temperature of from about 25 DEG C to about 45 DEG C; (b) a first outer layer comprising at least one olefinic polymer selected from ethylene/alpha olefin copolymer, ethylene/vinyl acetate copolymer, ethylene/alkyl acrylate copolymer, ethylene/acrylic acid copolymer, ionomer, propylene homopolymer, propylene copolymer, butylene homopolymer, butylene copolymer, low density polyethylene, high density polyethylene, and multi component ethylene/alpha-olefin interpenetrating network resin; and (c) a second outer layer comprising at least one olefinic polymer selected from ethylene/alpha olefin copolymer, ethylene/vinyl acetate copolymer, ethylene/alkyl acrylate copolymer, ethylene/acrylic acid copolymer, ionomer, propylene homopolymer, propylene copolymer, butylene homopolymer, butylene copolymer, low density polyethylene, high density polyethylene, and multi component ethylene/alpha-olefin interpenetrating network resin; wherein the film has: (i) a Young's modulus of between about 50,000 pounds and about 200,000 pounds per square inch in at least one of the longitudinal and transverse directions; (ii) a free shrink of between about 10% and about 80% at 240 DEG F in at least one of the longitudinal and transverse directions; and (iii) a shrink tension of less than about 400 pounds per square inch at 240 DEG F in at least one of the longitudinal and transverse directions. First and second intermediate layers including an ethylene copolymer having a melt index less than about 2.0 g/10 minutes can be optionally included. Alternatively, a film includes a core layer including an ethylene copolymer having melt index less than about 2.0 g/10 minutes; first and second intermediate layers including a homogeneous random alpha-olefin/cyclic olefin copolymer; and first and second outer layers including an olefinic polymer. These films having properties as disclosed above are suitable for packaging purposes.
Patent NZ-540027-A (NZ)
Title: Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
Inventor: ZELDIS JEROME B
IPC: A61K45/06
Filed: 2003-10-24
Abstract: Disclosed is the use of a JNK inhibitor or a pharmaceutically acceptable salt, solvate or stereoisomer thereof for the manufacture of a composition for treating, preventing, managing and/or modifying pain in a patient.
Patent NZ-545010-A (NZ)
Title: Method and means of multi-activation of ions and atoms with NMR and EPR.
Inventor: PAPPAS PANAGIOTIS T
IPC: G01R33/62
Filed: 2004-06-29
Abstract: A method and system for multi - activation of ions and atoms with NMR and EPR is provided. The system uses one inductor, which is formed of one, two or a few twisted or parallel conductors, and exposes a sample object in a pulsed and damped alternating magnetic field (B) without necessarily the employment of a second, constant intensity, magnetic field. In this way, the nuclei and/or the electrons of the sample object are activated, in the presence of a non-constant magnetic field (B), that gets infinite negative and positive values between successive damped positive and negative values, crossing through the zero value during a magnetic pulse. Thus, a wide nuclear NMR and electronic EPR multiple - resonance of the sample object is achieved.
Patent NZ-545725-A (NZ)
Title: Low noise back EMF sensing brushless DC motor
Inventor: HARWOOD JONATHAN DAVID
Filed: 2006-03-03
Abstract: Current is supplied to a permanent magnet rotor brushless dc motor having three phase windings for producing rotating magnetic flux, a three phase bridge inverter including a pair of series connected switching devices per phase, and in which the motor torque is controlled by pulse width modulation of the motor current, by a method designed to reduce the operational noise of the motor and reduce the cost of the controller and sensor components. In the method the switching devices are controlled to commutate current through successive combinations of three of the windings so that magnetic flux produced by the stator windings rotates in a desired direction by 60 degrees per commutation at a speed inversely proportional to the period between commutations, the motor torque and speed is controlled by pulse width modulation of the operation of that switching device which has been switched from an off state to an on state on each new commutation, and applying voltage to one out of the three windings on each new commutation for an active period less than the period between commutations. After expiry of the active period the periodic back EMF that is induced in one of the windings by the rotation of the permanent magnet rotor is sensed and digitised by detection of the zero crossings of the back EMF signal. Each commutation is caused to occur at times that are substantially defined by or derived from each logic transition in the digitised signal due to the zero crossings.
Patent NZ-556765-A (NZ)
Title: Use of a rapid-release tablet of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene carboxamide (rivaroxaban)
Inventor: MISSELWITZ FRANK
IPC: A61K31/00
Filed: 2006-01-19
Abstract: Disclosed is the use of a rapid-release tablet of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban, BAY 59-7939) for the manufacture of a medicament for the treatment of a thromboembolic disorder (such as ST Segment Elevation Myocardial Infarction (STEMI), Non ST Segment Elevation Myocardial Infarction (NSTEMI), unstable angina, reocclusion after angioplasty or aortocoronary bypass, pulmonary embolisms, deep vein thromboses or stroke) wherein the medicament is to be administered once daily for at least five consecutive days, wherein said inhibitor has a plasma concentration half life of 10 hours or less when orally administered to a human patient.
Patent NZ-561707-A (NZ)
Title: Wet gypsum accelerator and methods, composition, and product relating thereto
Inventor: YU QIANG
IPC: C04B11/00
Filed: 2005-04-27
Abstract: Disclosed is a wet gypsum accelerator, comprising ground calcium sulfate dihydrate with a mean particle size from 0.5 to 2 microns, water, and either an organic phosphonic compound, a phosphate-containing compound, or a mixture of both. Also disclosed is a method of manufacture, and use, of the accelerator.
Patent NZ-564319-A (NZ)
Title: Navigation device with camera-info
Inventor: GEELAN PIETER ANDREAS
Filed: 2005-06-06
Abstract: A navigation device is provided. The device includes a display and a camera formed integrally with the navigation device which provides an image to the device via a feed. The navigation device is configured to display a combination of the camera image from the feed and navigation directions on the display by superimposing the directions over the camera image such that the position of the navigation directions are in a predefined spatial relationship with respect to the corresponding parts of the camera image. A method for providing the device as well as details of a sensor system to provide the direction and orientation of the device is also disclosed.
Patent NZ-565402-A (NZ)
Title: Method for production of carboxylate alkyl esters
Inventor: KONCAR MICHAEL
IPC: C09K23/00
Filed: 2006-07-24
Abstract: Disclosed is a process for the production of carboxylic acid esters by esterification of carboxylic acids and/or transesterification of carboxylic acid esters with methanol or ethanol in the presence of a liquid metal catalyst, characterized in that the liquid metal catalyst is the alkaline earth metal salt of a carboxylic acid and that, upon completion of the esterification or transesterification, respectively, the metal catalyst is used for another esterification or transesterification, respectively.
Patent NZ-567049-A (NZ)
Title: Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
Inventor: ZELDIS JEROME B
IPC: A61K31/515
Filed: 2006-10-03
Abstract: Disclosed is the use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione in the manufacture of a medicament for the treatment of chronic lymphocytic leukaemia, wherein the medicament is prepared for administration of escalating doses of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione from a starting dose of between about 2.5 mg/day and about 5 mg/day to a maximum dose of between about 5 mg/day and about 15 mg/day, wherein said dose is escalated every 7 to 28 days.
Patent NZ-579501-A (NZ)
Title: Fractionation of a lignocellulosic material
Inventor: EDYE LESLIE ALAN
IPC: C13B10/14
Filed: 2008-02-07
Abstract: Provided is a bi-phasic method for fractionating a lignocellulosic material, the method comprising; contacting the lignocellulosic material with an ionic liquid and dissolving the lignocellulosic material therein; providing a second liquid which is immiscible with the ionic liquid and is also a non-solvent for cellulose; adding the second liquid to the ionic liquid so as to form a biphasic system which comprises an ionic liquid phase essentially free of lignocellulose and a second liquid phase comprising lignin in solution and cellulose as a precipitate; separating the two phases and recovering the precipitated cellulose from the separated second liquid phase. The fractionated cellulose can further be hydrolysed to obtain glucose and further fermented to obtain ethanol.
Patent NZ-581306-A (NZ)
Title: Multivalent vaccines comprising recombinant viral vectors
Inventor: HAVENGA MENZO JANS EMCO
IPC: A61K35/761
Filed: 2005-11-15
Abstract: Provided is the use a Mycobacterium antigen TB10.4 in the manufacture of a genetic adjuvant, to be used in treatment or prophylaxis of tuberculosis. The antigen may be Ag85A or Ag85B or an antigen from a non-mycobacterium species. (62) Divided Out of 555907
Patent NZ-585563-A (NZ)
Title: Pharmaceutical compositon for cleansing of the bowel
Inventor: XU HAIJUN
IPC: A61P1/10
Filed: 2008-12-05
Abstract: Disclosed is a pharmaceutical composition comprising a docusate; an osmotic laxative; and a benzoate; wherein the composition is in the form of a solution. Also disclosed is a single use package for rectal administration for cleansing of the bowel comprising a single dose of a pharmaceutical composition comprising a docusate; an osmotic laxative; and a benzoate wherein the composition is in the form of a solution. Further disclosed is the use of a benzoate for increasing the stability of the pharmaceutical composition.
Patent NZ-587832-A (NZ)
Title: Apparatus for stripping off material from a conveyor belt of a belt conveyor
Inventor: DUENNWALD WILFRIED
IPC: B65G45/16
Filed: 2009-04-02
Abstract: 587832 Disclosed is an apparatus for stripping off of particularly adhesive material from a conveyer belt (2) of a belt conveyer. The belt conveyer is in the region of the curve of a discharge drum below the discharge point on the belt conveyer having a stripper body (4). The stripping body (4) comprises a carrying element (3a) formed by a steel cable and/or metal chain. The carrying element (3a) pulls the stripping body (4) onto the conveyer belt (2). The stripper body (4) further comprises a raising element (3b) which is arranged in a spaced apart relationship to the carrying element (3a) to the stripping body (4). The raising element (3b) carries the stripping body (4) if the latter is displaced in the belt running direction.
Patent NZ-587837-A (NZ)
Title: Creating stereoscopic volume for a 2-D image by offsetting duplicated portions of the image
Inventor: TURNER TARA HANDY
IPC: G02B27/22
Filed: 2010-09-07
Abstract: Disclosed is a method for generating stereoscopic volume for a two dimensional digital image. The method comprises: obtaining a first two dimensional image comprising a first image portion and a second image portion; generating a second two dimensional image comprising a duplicate of the first image portion and a duplicate of the second image portion; and horizontally offsetting the first image portion relative to the duplicate of the first image portion a first amount and the second image portion relative to the duplicate of the second image a second amount, different from the first amount. The first image and the second image are displayed substantially contemporaneously for stereoscopic viewing of the image
Patent NZ-593077-A (NZ)
Title: Void former with a flexible insert for locking to an anchor head
Inventor: CONNELL ROBERT URQUHART
IPC: E04G15/04
Filed: 2006-09-05
Abstract: A void former for use with a lifting anchor cast into a concrete component. The void former is of two piece construction comprising a flexible element and a separate body which is substantially rigid. The flexible element is engageable with the head of the lifting anchor and is maintained in position by a snap fit with the rigid body which also acts to maintain the shape of the void during casting. After casting the rigid body is removed from the flexible element to thereby permit the flexible element to be disengaged from the lifting anchor by manipulation. The void former is thereby removable after casting without destruction of the void former and is thereby suitable for repeated use.
Patent NZ-602378-A (NZ)
Title: Diverter
Inventor: LEWIS LINDSAY RONALD
IPC: C02F1/26
Filed: 2012-09-12
Abstract: 602378 A diverter for use with a rain water collecting system having a conduit leading to a water storage tank. The diverter has a reservoir for receiving the liquid diverted from the rain water collecting system, a coupling which is configured to be connected to a conduit of the rain water collecting system, a flexible conduit between the coupling and the reservoir and a valve that allows the liquid to flow into the reservoir through an inlet and substantially inhibits liquid flowing out of the reservoir through the inlet. The valve is arranged such that when a volume of liquid in the reservoir reaches a predetermined level, the valve will close the inlet to substantially inhibit liquid flowing into the reservoir.
Patent NZ-613580-A (NZ)
Title: N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
Inventor: CARTER PERCY H
IPC: C07D487/04
Filed: 2010-10-12
Abstract: The disclosure relates to processes for preparing the compound N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide represented by the structural formula (I) and the process scheme shown herein, and compounds that are useful intermediates of the process., The present disclosure also provides N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a pharmaceutically acceptable salt or solvate thereof, having unexpected dual CCR-2 and CCR-5 receptor activity. Crystalline forms, metabolites, pharmaceutical compositions containing the same and methods of using the same as agents for the treatment of inflammatory diseases, allergic, autoimmune, metabolic, cancer and/or cardiovascular diseases.
Patent NZ-619027-A (NZ)
Title: Transdermal parasiticidal formulations
Inventor: KAREN YERITSYAN
IPC: C07D513/04
Filed: 2012-12-18
Abstract: Provided are transdermal parasiticidal formulations comprising levamisole, an anthelmintic agent, dissolved in a solution that includes isopropyl myristate and D-limonene. The formulations provided may further comprise at least one macrocyclic lactone. Preferable macrocyclic lactone compounds include abamectin, moxidectin, eprinomectin, selamectin, ivermectin and milbemycins. Further provided are methods of treating endo-parasite or ecto-parasitic infestations in non-human animals through the topical administration of the formulations.
Patent NZ-621479-A (NZ)
Title: A soil nutritional additive with disease control composition and a method of producing thereof
Inventor: METCALF DEAN
IPC: C05G3/60
Filed: 2012-07-31
Abstract: A method for producing an inoculated compost substrate includes the step of inoculation of a pure culture of a microorganism into a compost substrate. The inoculation takes place when the following conditions have been met in the compost substrate: the compost substrate temperature exceeds 40 Degrees Celsius for a period of not shorter than ten days, the composite substrate temperature towards the conclusion of a Thermophilic Stage of composting has dropped below 35 Degrees Celsius, compost Substrate internal Carbon Dioxide atmosphere has a Carbon Dioxide level of less than 15%; the compost substrate has a pH in the range of 4.5 to 8.0; the compost substrate moisture content is within the range of 30-55%; compost substrate ammonium content is no higher than 15mg/litre; and the compost substrate aerated with no significant or measurable accumulation of Hydrogen Sulphide.
Patent NZ-626042-A (NZ)
Title: Floor tile expansion joint
Inventor: MACNEIL DAVID F
IPC: E04F15/02
Filed: 2014-06-10
Abstract: Disclosed is a floor tile expansion joint (100) for use in creating a flooring surface (see figure 1) on an underlying surface. The expansion joint comprises first and second expansion bodies (202a, 202b). The first expansion body has a first web (204a), a plurality of first edge surfaces, including a first outer edge surface (222), and at least one first connector (see 214, figure 2B). The second expansion body has a second web (204b), a plurality of second edge surfaces, including a second outer edge surface (220), and at least one second connector (see 212, figure 2B). The first and second connectors are connectable to corresponding connectors on adjacent floor tiles. The first expansion body is provided with at least two spaced apart fingers (206) projecting from its inner margin, whereby the fingers define channels (228) therebetween. Similarly, the second expansion body is provided with at least one finger projecting from its inner margin. The fingers of the first and second expansion bodies slidably engage the respective channels of the other of the expansion bodies. The floor tile expansion joint allows adjacent connected floor tiles to thermally contract and expand while keeping the underlying floor surface covered. A system, further including modular floor tiles, is also disclosed.
Patent NZ-626616-A (NZ)
Title: Easily dissociable wheelchair
Inventor: BRENNER SIMON
IPC: A61G5/10
Filed: 2012-12-21
Abstract: A wheelchair (10) is disclosed. The wheelchair (10) comprises a seat module (10), a backrest module (20), a front frame module (30), and a rear wheel module (40). The seat module (10) includes a seat frame (see 11, figure 2) supporting a seat (12). The backrest module (20) includes a backrest frame (21) connected to the seat frame (11) and supports a backrest (22). The front frame module (30) includes a front frame (31). The front frame (31) includes left and right bended legs (31a, 31b) removably connected at their upper end to the seat frame (11) and at their lower end to a footrest (32). The bended legs (31a, 31b) are supported by caster wheel assemblies (35, 36) via caster supports (34). The rear wheel module (40) includes left and right rear wheels (41a, 41b) pivotally connected to an axle (42). The rear wheel module (40) is removably connected to the seat module (10) through left and right connecting elements (43a, 43b). The seat frame (11) consists of left and right longitudinal profiles (11a, 11b) extending in the same plane. Wherein said left and right connecting elements are configured so as to permit a step-less adjustment of the position of the rear wheel module with regard to the seat module in a direction orthogonal to the plane defined by the seat frame.
Patent NZ-709141-A (NZ)
Title: Shutter panel for an architectural opening
Inventor: HOLFORD MICHAEL
IPC: E06B9/04
Filed: 2013-03-14
Abstract: Louvered shutters for architectural openings, such as doors, windows, and the like, have taken numerous forms for many years. Louvered shutters generally provide adjustable light and privacy control through the inclusion of multiple rotatable louvers. In operation, consumers may rotate the louvers to a desired position that provides a preferred amount of light and privacy. A shutter panel for an architectural opening is provided. The shutter panel may include a frame and a louver rotatably coupled to the frame. The louver may be automatically closable based on an angular orientation of the louver. The shutter panel may include a closure device coupled to the louver. The closure device may be actuated based on the angular orientation of the louver. The shutter panel may include a damping device coupled to the louver. The damping device may be actuated based on the angular orientation of the louver. The shutter panel may include a tension device coupled to the louver.
Patent NZ-729685-A (NZ)
Title: Process for manufacturing pyrimidine sulfamide derivatives
Inventor: ABELE STEFAN
IPC: C07D401/12
Filed: 2015-02-13
Abstract: The invention relates to a process for manufacturing the compound of formula I wherein R is n-propyl, or a salt thereof, said process comprising the reaction of the compound of formula I-1 wherein X is Br, Cl or F, or a salt thereof, with the compound of formula I-2 wherein R is n-propyl, or a salt thereof, in the presence of a base, and, when X is Br or Cl, in the presence of tetra-n-butyl ammonium fluoride hydrate or cesium fluoride with higher purity and yield. The invention further relates to the compound of formula I-1 and uses thereof.
Patent NZ-740231-A (NZ)
Title: Bottle holder for a syringe
Inventor: EISELE MELANIE
IPC: A61J1/16
Filed: 2018-03-20
Abstract: A bottle holder for a syringe is provided, wherein the bottle holder (2) comprises a stop surface (26), a piercing hollow spike (27) protruding beyond the stop surface and extending in a first direction, a guideway (28) and a first and a second clamping element (29, 30, 31), which are arranged one on another along the first direction and are mounted in the guideway (28) so as to be moveable along a second direction transverse to the first direction. Each clamping element comprises a through-hole and is moveable back and forth between an insertion position and a clamping position. When the clamping elements are in the insertion position, a neck (19) of a bottle (3) can be moved through the through-holes until the front end of the bottle abuts against the stop surface, resulting in the piercing hollow spike piercing a film (21) at the front end of the bottle, wherein at least one of the clamping elements, when in its clamping position, presses against the neck of the bottle. The disclosed bottle holder can secure bottles of varying neck diameter or length without requiring adapters or other changeable parts, reducing the effort when changing between different sized bottles.